---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-064650"
form_type: "8-K"
ticker: "ISPC"
cik: "0001558569"
company_name: "iSpecimen Inc."
filed_at: "2023-05-25T23:59:59+00:00"
generated_at: "2026-06-14T14:30:19.267974+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# iSpecimen shareholders approve plan amendment increasing share reserve 3x to 1.87M

## Summary
- Stockholders approved amendment to 2021 plan: shares reserved increased from 608,000 to 1,869,500 shares.
- Annual automatic share increase mechanism removed; clawback/recoupment provision added.
- Three Class II directors (Brooks, Curley, Mock) elected to three-year terms.
- Proposal to allow director removal without cause failed (3.8M for vs required majority of outstanding shares).
- Ratification of Wolf & Company as auditor for FY2023 approved (6,421,007 for).

## SEC filing metadata
- accession: 0001104659-23-064650
- form_type: 8-K
- ticker: ISPC
- cik: 0001558569
- company_name: iSpecimen Inc.
- filed_at: 2023-05-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/tm2316924d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-064650
- JSON: https://secwatch.observer/filing/0001104659-23-064650.json
- Plain text: https://secwatch.observer/filing/0001104659-23-064650.txt

## Key facts
- Shareholder Votes
  iSpecimen Inc. shareholders approved Approval of an amendment to the Second A&R 2021 Plan to increase the number of shares reserved for issuance from 608,000 to 1,869,500 shares.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal No. 3 was approved by a majority of the votes cast.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm
- Shareholder Votes
  iSpecimen Inc. shareholders approved Approval of amendments to the Second A&R 2021 Plan to remove automatic annual increase and add clawback provisions.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal No. 2 was approved by a majority of the votes cast.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm
- Shareholder Votes
  iSpecimen Inc. shareholders approved Election of three Class II directors each to serve for a three-year term that expires at the 2026 annual meeting of stockholders.
  - Proposal: director election
  - Outcome: passed
  source text: Brooks III 3,900,970 704,582 1,914,191 Tracy Curley 4,056,320 549,232 1,914,191 Theresa L. Mock 4,412,763 192,789 1,914,191 Each nominee was elected.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm
- Shareholder Votes
  iSpecimen Inc. shareholders approved Ratification of appointment of Wolf & Company, P.C. as independent registered public accounting firm for the year ending December 31, 2023.
  - Proposal: auditor ratification
  - Outcome: passed
  source text: Proposal No. 5 was approved by a majority of the votes cast.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm
- Shareholder Votes
  iSpecimen Inc. shareholders rejected Approval of an amendment to the Fourth Amended and Restated Certificate of Incorporation to permit removal of directors by stockholders without cause.
  - Proposal: charter amendment
  - Outcome: failed
  source text: Proposal No. 4 was not approved, because votes in favor of this proposal did not represent a majority of the voting shares entitled to vote thereon, as required.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923064650/0001104659-23-064650-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.